Glycodelin is a potential novel follow-up biomarker for malignant pleural mesothelioma.
about
Glycodelin is a potential novel follow-up biomarker for malignant pleural mesothelioma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Glycodelin is a potential novel follow-up biomarker for malignant pleural mesothelioma.
@en
Glycodelin is a potential novel follow-up biomarker for malignant pleural mesothelioma.
@nl
type
label
Glycodelin is a potential novel follow-up biomarker for malignant pleural mesothelioma.
@en
Glycodelin is a potential novel follow-up biomarker for malignant pleural mesothelioma.
@nl
prefLabel
Glycodelin is a potential novel follow-up biomarker for malignant pleural mesothelioma.
@en
Glycodelin is a potential novel follow-up biomarker for malignant pleural mesothelioma.
@nl
P2093
P2860
P356
P1433
P1476
Glycodelin is a potential novel follow-up biomarker for malignant pleural mesothelioma.
@en
P2093
Felix J F Herth
Hendrik Dienemann
Marc A Schneider
Michael Meister
Michael Thomas
Thomas Muley
P2860
P304
71285-71297
P356
10.18632/ONCOTARGET.12474
P407
P577
2016-10-04T00:00:00Z